Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1991-1-28
|
pubmed:abstractText |
Recombinant plasmids containing v-myb' (803 bp fragment of the 3' end of v-myb) were constructed to induce sense or antisense v-myb' RNA expression with dexamethasone in human cells. These plasmids were used as a tool for the investigation of the role of c-myb gene in human leukemia cell proliferation and differentiation. They were transfected by electroporation into the K562 human leukemia cell line derived from a patient with chronic myelogenous leukemia in blastic crisis. After induction of transcription by dexamethasone, the plasmid with antisense v-myb' repressed the expression of p75c-myb from the endogenous c-myb gene of K562 cells. It also reduced the proliferation rate of K562 cells to 50% of the control level, and induced these K562 cells to express the myelomonocytic differentiation cell surface marker CD13 and increased NBT reducing activity. The plasmid with sense v-myb' did not have an effect on p75c-myb expression, the proliferation of K562 cells or the expression of myelomonocytic differentiation phenotypes. These observations suggest that antisense v-myb' RNA represses p75c-myb expression and that a decrease of p75c-myb suppresses K562 cell proliferation and induces its differentiation towards the myelomonocytic lineage.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD13,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myb,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Antisense
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0145-2126
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:geneSymbol |
v-myb'
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
831-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1979645-Antigens, CD13,
pubmed-meshheading:1979645-Antigens, Differentiation, Myelomonocytic,
pubmed-meshheading:1979645-Blast Crisis,
pubmed-meshheading:1979645-Cell Differentiation,
pubmed-meshheading:1979645-Cell Division,
pubmed-meshheading:1979645-Gene Expression,
pubmed-meshheading:1979645-Humans,
pubmed-meshheading:1979645-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:1979645-Oncogenes,
pubmed-meshheading:1979645-Plasmids,
pubmed-meshheading:1979645-Proto-Oncogene Proteins,
pubmed-meshheading:1979645-Proto-Oncogene Proteins c-myb,
pubmed-meshheading:1979645-Proto-Oncogenes,
pubmed-meshheading:1979645-RNA, Antisense,
pubmed-meshheading:1979645-Recombination, Genetic,
pubmed-meshheading:1979645-Tumor Cells, Cultured
|
pubmed:year |
1990
|
pubmed:articleTitle |
Effects of the antisense v-myb' expression on K562 human leukemia cell proliferation and differentiation.
|
pubmed:affiliation |
First Department of Internal Medicine, Kagawa Medical School, Japan.
|
pubmed:publicationType |
Journal Article
|